251 related articles for article (PubMed ID: 16286246)
1. Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance.
Lim KH; Counter CM
Cancer Cell; 2005 Nov; 8(5):381-92. PubMed ID: 16286246
[TBL] [Abstract][Full Text] [Related]
2. Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling.
Lee SG; Su ZZ; Emdad L; Sarkar D; Franke TF; Fisher PB
Oncogene; 2008 Feb; 27(8):1114-21. PubMed ID: 17704808
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic Ras/Her-2 mediate hyperproliferation of polarized epithelial cells in 3D cultures and rapid tumor growth via the PI3K pathway.
Janda E; Litos G; Grünert S; Downward J; Beug H
Oncogene; 2002 Aug; 21(33):5148-59. PubMed ID: 12140765
[TBL] [Abstract][Full Text] [Related]
4. Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway.
Tang Y; Nakada MT; Rafferty P; Laraio J; McCabe FL; Millar H; Cunningham M; Snyder LA; Bugelski P; Yan L
Mol Cancer Res; 2006 Jun; 4(6):371-7. PubMed ID: 16778084
[TBL] [Abstract][Full Text] [Related]
5. K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling.
Campbell PM; Groehler AL; Lee KM; Ouellette MM; Khazak V; Der CJ
Cancer Res; 2007 Mar; 67(5):2098-106. PubMed ID: 17332339
[TBL] [Abstract][Full Text] [Related]
6. PTEN, more than the AKT pathway.
Blanco-Aparicio C; Renner O; Leal JF; Carnero A
Carcinogenesis; 2007 Jul; 28(7):1379-86. PubMed ID: 17341655
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells.
Calleros L; Sánchez-Hernández I; Baquero P; Toro MJ; Chiloeches A
Carcinogenesis; 2009 Oct; 30(10):1670-7. PubMed ID: 19700418
[TBL] [Abstract][Full Text] [Related]
8. Human urine extract CDA-2 induces apoptosis of myelodysplastic syndrome-derived MUTZ-1 cells through the PI3K/Akt signaling pathway in a caspase-3-dependent manner.
Huang J; Yang M; Liu H; Jin J
Acta Pharmacol Sin; 2008 Aug; 29(8):951-64. PubMed ID: 18664328
[TBL] [Abstract][Full Text] [Related]
9. Parallel signaling pathways in endothelin-1-induced proliferation of U373MG astrocytoma cells.
He S; Dibas A; Yorio T; Prasanna G
Exp Biol Med (Maywood); 2007 Mar; 232(3):370-84. PubMed ID: 17327470
[TBL] [Abstract][Full Text] [Related]
10. Involvement of H- and N-Ras isoforms in transforming growth factor-beta1-induced proliferation and in collagen and fibronectin synthesis.
Martínez-Salgado C; Fuentes-Calvo I; García-Cenador B; Santos E; López-Novoa JM
Exp Cell Res; 2006 Jul; 312(11):2093-106. PubMed ID: 16624289
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic K-RAS is required to maintain changes in cytoskeletal organization, adhesion, and motility in colon cancer cells.
Pollock CB; Shirasawa S; Sasazuki T; Kolch W; Dhillon AS
Cancer Res; 2005 Feb; 65(4):1244-50. PubMed ID: 15735008
[TBL] [Abstract][Full Text] [Related]
12. Constitutive activation of the Raf-MAPK pathway causes negative feedback inhibition of Ras-PI3K-AKT and cellular arrest through the EphA2 receptor.
Menges CW; McCance DJ
Oncogene; 2008 May; 27(20):2934-40. PubMed ID: 18059341
[TBL] [Abstract][Full Text] [Related]
13. Targeting MAPK (Ras/ERK) and PI3K/Akt pathways in pituitary tumorigenesis.
Cakir M; Grossman AB
Expert Opin Ther Targets; 2009 Sep; 13(9):1121-34. PubMed ID: 19637976
[TBL] [Abstract][Full Text] [Related]
14. Delineating v-Src downstream effector pathways in transformed myoblasts.
Ciuffini L; Castellani L; Salvati E; Galletti S; Falcone G; Alemà S
Oncogene; 2008 Jan; 27(4):528-39. PubMed ID: 17637741
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and biological characterization of tumor-associated mutations of p110alpha.
Denley A; Gymnopoulos M; Hart JR; Jiang H; Zhao L; Vogt PK
Methods Enzymol; 2008; 438():291-305. PubMed ID: 18413256
[TBL] [Abstract][Full Text] [Related]
16. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.
Lue H; Thiele M; Franz J; Dahl E; Speckgens S; Leng L; Fingerle-Rowson G; Bucala R; Lüscher B; Bernhagen J
Oncogene; 2007 Aug; 26(35):5046-59. PubMed ID: 17310986
[TBL] [Abstract][Full Text] [Related]
17. Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice.
Gupta S; Ramjaun AR; Haiko P; Wang Y; Warne PH; Nicke B; Nye E; Stamp G; Alitalo K; Downward J
Cell; 2007 Jun; 129(5):957-68. PubMed ID: 17540175
[TBL] [Abstract][Full Text] [Related]
18. The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase.
Martin MJ; Melnyk N; Pollard M; Bowden M; Leong H; Podor TJ; Gleave M; Sorensen PH
Mol Cell Biol; 2006 Mar; 26(5):1754-69. PubMed ID: 16478996
[TBL] [Abstract][Full Text] [Related]
19. Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis?
Repasky GA; Chenette EJ; Der CJ
Trends Cell Biol; 2004 Nov; 14(11):639-47. PubMed ID: 15519853
[TBL] [Abstract][Full Text] [Related]
20. Functional inhibition of PI3K by the betaGBP molecule suppresses Ras-MAPK signalling to block cell proliferation.
Wells V; Downward J; Mallucci L
Oncogene; 2007 Dec; 26(55):7709-14. PubMed ID: 17603562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]